Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T KING

Showing results (991-1000 of 1,347) with videos related to

Pageof 135
Sort By:
NAM Journal|June 10, 2026
Mutagenicity of EAT-positive NDSRIs in HepaRG spheroidsJi-Eun Seo, Hannah S Xu, Javier R Revollo, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 3, 2025
The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in NeonatesCourtney J Wusthoff, Adam L Numis, Ronit M Pressler, et al.
Molecular and Biochemical Parasitology|February 13, 2001
Proteolysis of human hemoglobin by schistosome cathepsin DP J Brindley, B H Kalinna, J Y Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM studyAndrew Macann, Tsien Fua, Chris G Milross, et al.
Regulatory Toxicology and Pharmacology : RTP|May 16, 2024
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)Naomi L Kruhlak, Marianne Schmidt, Roland Froetschl, et al.
Cancer Medicine|July 5, 2021
International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative studyAmeeta Retzer, Melanie Calvert, Khaled Ahmed, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
BMJ Open|February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocolAmeeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
ACS Applied Materials & Interfaces|March 2, 2025
Two-Dimensional Siloxene Nanosheets: Understanding the Effect of Heat Treatment on the Surface Chemistry and Resulting Electrochemistry in Lithium-Based BatteriesJessica Luo, Edelmy J Marin Bernardez, David J Arnot, et al.
Thyroid : Official Journal of the American Thyroid Association|October 30, 2024
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid CancerMicha J Pilz, Simone Seyringer, Susanne Singer, et al.
Pageof 135

Showing results (991-1000 of 1,347) with videos related to

Sort By:
Pageof 135
NAM Journal|June 10, 2026
Mutagenicity of EAT-positive NDSRIs in HepaRG spheroidsJi-Eun Seo, Hannah S Xu, Javier R Revollo, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 3, 2025
The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in NeonatesCourtney J Wusthoff, Adam L Numis, Ronit M Pressler, et al.
Molecular and Biochemical Parasitology|February 13, 2001
Proteolysis of human hemoglobin by schistosome cathepsin DP J Brindley, B H Kalinna, J Y Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM studyAndrew Macann, Tsien Fua, Chris G Milross, et al.
Regulatory Toxicology and Pharmacology : RTP|May 16, 2024
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)Naomi L Kruhlak, Marianne Schmidt, Roland Froetschl, et al.
Cancer Medicine|July 5, 2021
International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative studyAmeeta Retzer, Melanie Calvert, Khaled Ahmed, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
BMJ Open|February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocolAmeeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
ACS Applied Materials & Interfaces|March 2, 2025
Two-Dimensional Siloxene Nanosheets: Understanding the Effect of Heat Treatment on the Surface Chemistry and Resulting Electrochemistry in Lithium-Based BatteriesJessica Luo, Edelmy J Marin Bernardez, David J Arnot, et al.
Thyroid : Official Journal of the American Thyroid Association|October 30, 2024
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid CancerMicha J Pilz, Simone Seyringer, Susanne Singer, et al.
Pageof 135